Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)

Wuhan Hvsen Biotechnology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	209.05	326.14	293.61	424.04	1,068	345.39
Short-Term Investments	-	-	-	-	-	201.01
Trading Asset Securities	283.81	200.97	304.26	361.68	30.22	240.63
Cash & Short-Term Investments	492.86	527.11	597.87	785.72	1,098	787.03
Cash Growth	4.96%	-11.83%	-23.91%	-28.47%	39.57%	653.45%
Accounts Receivable	478.45	446.27	369.11	354.41	249.4	235.4
Other Receivables	10.74	19.8	7.42	1.7	10.07	2.47
Receivables	489.19	466.07	376.53	356.11	259.46	237.87
Inventory	254.46	248.16	228.67	199.01	231.55	127.27
Other Current Assets	33.83	71.24	62.91	10.64	9.42	24.99
Total Current Assets	1,270	1,313	1,266	1,351	1,599	1,177
Property, Plant & Equipment	1,529	1,543	1,566	1,498	1,007	412.33
Other Intangible Assets	111.46	114.44	104.17	106.87	110.06	95.77
Long-Term Accounts Receivable	-	-	-	-	-	2.01
Long-Term Deferred Tax Assets	21.68	27.17	21.65	12.91	10.46	8.25
Long-Term Deferred Charges	1.03	1.9	2.72	0.37	-	-
Other Long-Term Assets	23.68	15.25	14.78	19.4	15.46	56.72
Total Assets	2,958	3,015	2,975	2,989	2,742	1,752
Accounts Payable	318	507.3	472.47	489.7	311.33	194.44
Accrued Expenses	24.08	22.88	26.72	33.67	27.59	26.55
Short-Term Debt	276.09	316.78	240.32	220.08	100	63
Current Portion of Long-Term Debt	-	16.32	0.27	-	-	-
Current Portion of Leases	-	-	-	-	6.42	9.7
Current Income Taxes Payable	19.92	0.04	3.17	6.25	2.56	8.01
Current Unearned Revenue	17.22	13.47	10.27	15.62	13.87	13.34
Other Current Liabilities	89.84	46.52	27.86	39.6	41.5	23.64
Total Current Liabilities	745.17	923.32	781.08	804.93	503.27	338.67
Long-Term Debt	35.51	555.45	601.66	570.36	574.56	-
Long-Term Leases	-	-	-	-	-	6.42
Long-Term Unearned Revenue	54.38	58.34	62.34	48.89	42.08	24.7
Long-Term Deferred Tax Liabilities	2.88	11.37	20.26	21.82	-	-
Other Long-Term Liabilities	2	1	0.85	1.69	2.9	3.29
Total Liabilities	839.94	1,549	1,466	1,448	1,123	373.08
Common Stock	202.33	165.77	165.89	166.05	166.25	110.51
Additional Paid-In Capital	1,451	880.63	874.01	877.08	881.6	926.89
Retained Earnings	476.51	330.21	394.92	427.11	429.31	341.76
Treasury Stock	-17.78	-17.57	-52.42	-55.73	-9.52	-
Comprehensive Income & Other	-3.79	98.54	126.89	126.92	151.21	-
Total Common Equity	2,108	1,458	1,509	1,541	1,619	1,379
Minority Interest	9.68	7.63	-	-	-	-
Shareholders' Equity	2,118	1,465	1,509	1,541	1,619	1,379
Total Liabilities & Equity	2,958	3,015	2,975	2,989	2,742	1,752
Total Debt	311.61	888.56	842.24	790.45	680.98	79.12
Net Cash (Debt)	181.25	-361.45	-244.38	-4.72	417.47	707.91
Net Cash Growth	-	-	-	-	-41.03%	3656.44%
Net Cash Per Share	1.00	-2.18	-1.47	-0.03	2.52	4.81
Filing Date Shares Outstanding	201.58	165.01	163.5	163.67	166.25	165.76
Total Common Shares Outstanding	201.58	165.01	163.5	163.67	166.25	165.76
Working Capital	525.17	389.27	484.9	546.55	1,096	838.48
Book Value Per Share	10.46	8.83	9.23	9.42	9.74	8.32
Tangible Book Value	1,996	1,343	1,405	1,435	1,509	1,283
Tangible Book Value Per Share	9.90	8.14	8.59	8.77	9.08	7.74
Buildings	-	670.73	647.31	521.54	385.01	78.36
Machinery	-	1,231	1,135	798.62	204.86	110.35
Construction In Progress	-	18.15	53.13	332.51	473.25	267.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.